The U.S. government says it’s cancelling a planned order of monoclonal antibody treatments for Covid-19 infections and warned that the country could eventually run short of vaccines because of a lack of funding.
The White House made the announcement Tuesday as it renews calls for Congress to authorize a fresh round of funding for the government’s Covid-19 response. Weeks of effort have fallen flat, leaving the administration to begin to claw back shipments and warn they may soon end.
The funding is needed for new orders of treatments, to ensure fourth doses of vaccines are available for all Americans if ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.